Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis-Reference-Cited by-同舟云学术

Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis

Published:2007-09 Issue:9 Volume:51 Page:3445-3448
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Julian Kathleen¹,Kosowska-Shick Klaudia¹,Whitener Cynthia¹,Roos Martin²,Labischinski Harald²,Rubio Aileen³,Parent Leslie¹,Ednie Lois¹,Koeth Laura⁴,Bogdanovich Tatiana¹,Appelbaum Peter C.¹

Affiliation:

1. Pennsylvania State University Milton S. Hershey Medical Center, Hershey, Pennsylvania

2. Combinature Biopharm AG, Berlin, Germany

3. Cubist Pharmaceuticals, Lexington, Massachusetts

4. Laboratory Specialists, Inc., Westlake, Ohio

Abstract

ABSTRACT We analyzed the emergence of daptomycin nonsusceptibility in a patient with persistent vancomycin-intermediate Staphylococcus aureus (VISA) bacteremia. The daptomycin-nonsusceptible VISA's cell wall demonstrated a reduction in muramic acid O -acetylation, a phenotypic parameter not previously reported for VISA; some isolates also contained a single point mutation in the mprF gene.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00559-07

Reference25 articles.

1. Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance

2. Performance standards for antimicrobial susceptibility testing 2006

3. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

4. Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused byStaphylococcus aureus

5. Fridkin, S. K., J. Hageman, L. K. McDougal, J. Mohammed, W. R. Jarvis, T. M. Perl, F. C. Tenover, and the Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. 2003. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis.36:429-439.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Analysis of Daptomycin-non-Susceptible Methicillin-Resistant Staphylococcus aureus Reveals the Presence of Variants That Contribute to Daptomycin Resistance;Current Microbiology;2024-01-11

2. Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin;Expert Review of Anti-infective Therapy;2023-02-10

3. Bacterial cell membranes and their role in daptomycin resistance: A review;Frontiers in Molecular Biosciences;2022-11-14

4. Genome-Wide Association Studies for the Detection of Genetic Variants Associated With Daptomycin and Ceftaroline Resistance in Staphylococcus aureus;Frontiers in Microbiology;2021-02-15

5. Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution—T345I in MprF of clinically isolated MRSA strains;PLOS ONE;2021-01-22